Santen Pharmaceutical Co. and Plano today announced a strategic alliance to tackle the global burden of myopia. Under this strategic alliance, Plano has secured an investment from Santen. Santen, through Plano, will initiate to tackle the burden of myopia using both a holistic approach and innovative technological solutions.
Read more: https://www.plano.co/form-a-strategic-alliance-to-tackle-the-global-burden-of-myopia
